Spironolactone Tablet, Film Coated
Product Images NDC 60687-487

12 FDA label images from American Health Packaging · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 60687-487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp46501

Ahp46501
Spironolactone 25 mg oral tablet imprinted with '660' on one side and blank on the other. The round, white tablet is part of American Health Packaging's prescription drug line for oral use.*
FDA Label Image

Ahp47601

Ahp47601
Spironolactone 25 mg oral tablet, white, oval with score line on both sides, imprinted with '551' on one side. Manufactured by American Health Packaging.*
FDA Label Image

Ahp48701

Ahp48701
Spironolactone 50 mg tablet, round and white, with imprint '562' on one side and a scored line on the other. Oral tablet form manufactured by American Health Packaging.*
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)
Chemical structure diagram of spironolactone, showing its steroidal ring system with attached functional groups including a lactone ring and thioacetate group.*
FDA Label Image

Figure 1. Survival By Treatment Group In Randomized Spironolactone Evaluation Study (Figure 1)

Figure 1. Survival By Treatment Group In Randomized Spironolactone Evaluation Study (Figure 1)
A Kaplan-Meier survival curve comparing probability over months between Spironolactone (n=822) and placebo (n=841) groups. The graph shows higher survival probability for Spironolactone group with a log-rank p-value less than 0.001.*
FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In Randomized Spironolactone Evaluation Study (Figure 2)

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In Randomized Spironolactone Evaluation Study (Figure 2)
A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4 showing relative effect favoring spironolactone or placebo.*
FDA Label Image

25 mg Spironolactone Tablets Carton (25 mg Spironolactone Tablets Carton)

25 mg Spironolactone Tablets Carton (25 mg Spironolactone Tablets Carton)
Label for Spironolactone 25 mg film-coated tablets, USP, in a package of 100 tablets (10 x 10). The product is Rx only and distributed by American Health Packaging, Columbus, Ohio. The label includes dosage strength, NDC 60687-465-01, storage instructions, and a QR code for prescribing information.*
FDA Label Image

25 mg Spironolactone Tablet 100 Blister (25mg Blister)

25 mg Spironolactone Tablet 100 Blister (25mg Blister)
Spironolactone 25 mg film-coated tablets label from American Health Packaging. The label includes the drug name, strength, dosage form, barcode, NDC number, and placeholder text for expiration date and lot number. The label design is repeated multiple times on the sheet.*
FDA Label Image

50 mg Spironolactone Tablets Carton (50 mg Spironolactone Tablets Carton)

50 mg Spironolactone Tablets Carton (50 mg Spironolactone Tablets Carton)
Label for Spironolactone 50 mg tablets, USP, film coated, oral dosage form. The package contains 100 tablets in a 10 by 10 count. The label includes the NDC 60687-476-01 and states Rx only. It is distributed by American Health Packaging, Columbus, Ohio.*
FDA Label Image

50 mg Spironolactone Tablet 100ud Blister (50mg Blister)

50 mg Spironolactone Tablet 100ud Blister (50mg Blister)
Packaging label for Spironolactone tablet, USP 50 mg film-coated oral tablets. The label includes the drug name, strength, barcode, expiration date, lot number fields, and the labeler American Health Packaging, Columbus, Ohio. Multiple identical labels are shown on the sheet.*
FDA Label Image

100 mg Spironolactone Tablets Carton (100 mg Spironolactone Tablets Carton)

100 mg Spironolactone Tablets Carton (100 mg Spironolactone Tablets Carton)
Spironolactone 100 mg tablets, USP, film coated, presented in a package of 100 tablets (10 blister packs of 10 each). The label indicates prescription-only status and includes storage instructions and manufacturer details, showing American Health Packaging as the distributor and Zydus Pharmaceuticals (USA) Inc. as the manufacturer.*
FDA Label Image

100 mg Blister (100 mg Spironolactone Tablet Blister)

100 mg Blister (100 mg Spironolactone Tablet Blister)
Spironolactone Tablet USP 100 mg film-coated tablets, labeled for oral use by American Health Packaging. The label shows multiple individual blister cards containing one tablet each, with lot number 1234567 and expiration date 02/22. The packaging is white with black text and includes barcodes and product identification information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.